A public change to healthier lifestyles with more physical activity and better nutrition, including caloric restriction, is required to address the obesity epidemic. Weight loss can be achieved by caloric restrictions; current research suggests that this may be achieved by consumption of slowly absorbed carbohydrates owing to the resulting prolonged satiety. Our rationale was to prolong the satiety of overweight volunteers by supplementation with a proprietary formulation Glucaffectâ¢ which delays absorption of carbohydrates. Glucaffectâ¢ provides potent a-glucosidase inhibitors of herbal source such PycnogenolÂ® , Madeglucylâ¢ and various others which obstruct absorption of carbohydrates, such as starch. Fifty overweight subjects received either Glucaffectâ¢ or an inactive control product for eight weeks. Consumption of Glucaffectâ¢ was found to statistically significantly lower blood-fasting glucose from baseline 145.3 mg/dL to 101.1 mg/dL (-30.4%) and Hba1c from 7.59% to 6.33% as compared to the control group where values decreased only marginally. The weight and the body mass index (BMI) decreased significantly from an average of 88.5 kg (BMI 26.8 kg/m2) to 81.3 kg (BMI 24.5 kg/m2) as compared to the control group. In conclusion, Glucaffectâ¢ enabled subjects with metabolic syndrome to achieve healthy BMI and blood glucose levels. Glucaffectâ¢ was well tolerated and no subject dropped out. Copyright Â© 2009 John Wiley & Sons, Ltd.
|Titolo:||Daily consumption of reliv glucaffectâ¢ for 8 weeks significantly lowered blood glucose and body weight in 50 subjects|
|Data di pubblicazione:||2009|
|Appare nelle tipologie:||1.1 Articolo in rivista|